LJM1R — Latvijas Juras Medicinas Centrs AS Cashflow Statement
0.000.00%
Last trade - 00:00- €6.28m
- €5.13m
- €10.29m
Annual cashflow statement for Latvijas Juras Medicinas Centrs AS, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.881 | 0.626 | -0.014 | 0.186 | 0.258 |
| Depreciation | |||||
| Non-Cash Items | — | 0.006 | 0.012 | 0.007 | 0 |
| Unusual Items | |||||
| Changes in Working Capital | -0.749 | 0.248 | 1.36 | -0.209 | -0.307 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.418 | 1.31 | 1.91 | 0.605 | 0.579 |
| Capital Expenditures | -1.11 | -0.844 | -2.48 | -0.436 | -0.191 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -1.11 | -0.844 | -2.48 | -0.436 | -0.191 |
| Total Cash Dividends Paid | |||||
| Cash from Financing Activities | -0.056 | -0.16 | -0.08 | 0 | -0.08 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.748 | 0.304 | -0.646 | 0.169 | 0.308 |